Osteogenesis Imperfecta Workup
- Author: Manoj Ramachandran, MBBS, MRCS, FRCS; Chief Editor: Harris Gellman, MD more...
Results from routine laboratory studies in patients with osteogenesis imperfecta (OI) are usually within reference ranges, and they are useful in ruling out other metabolic bone diseases.
An analysis of type I, III, and V collagens synthesized by fibroblasts may be helpful. Collagen synthesis analysis is performed by culturing dermal fibroblasts obtained during skin biopsy. The occurrence of false-negative results is not clear, although the rate may be about 15%. Results are negative in syndromes resembling OI.
Tests include the following:
Sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-PAGE)
Cyanogen bromide (CNBr) mapping
Thermal stability studies
An analysis of the amino acid composition of collagens may be useful.
DNA blood testing for gene defects has an accuracy of 60-94%. Prenatal DNA mutation analysis can be performed in pregnancies with risk of OI to analyze uncultured chorionic villus cells. Samples are obtained during chorionic villus sampling performed under ultrasonographic guidance when a mutation in another member of the family is already known.
Prenatal ultrasonography is most useful in evaluating OI types II and III. It is capable of detecting limb-length abnormalities at 15-18 weeks’ gestation. In its most severe form, the disease may be evident as early as 16 weeks’ gestation.
Mild forms of OI may result in normal findings on ultrasonography. Features include supervisualization of intracranial contents caused by decreased mineralization of calvaria (also calvarial compressibility), bowing of the long bones, decreased bone length (especially of the femur), and multiple rib fractures.
Obtain a radiographic skeletal survey after birth. Plain radiographs may depict the following three radiologic categories of OI:
Category I – Thin and gracile bones
Category II – Short and thick limbs
Category III – Cystic changes
Radiologic features commonly seen include the following:
Fractures – Commonly, transverse fractures and those affecting the lower limbs (see the first image below)
Excessive callus formation and popcorn bones - Multiple scalloped, radiolucent areas with radiodense rims
Skull changes - Wormian bones (see the second image below), enlargement of frontal and mastoid sinuses, and platybasia with or without basilar impression
Deformities of the thoracic cage - Fractured and beaded ribs (see the third and fourth images below) and pectus carinatum
Pelvic and proximal femoral changes - Narrow pelvis, compression fractures, protrusio acetabuli,  and shepherd’s-crook deformities of the femursAcute fractures are observed in radius and ulna. Multiple fractures can be seen in ribs. Old healing humeral fracture with callus formation is observed.
In mild OI (type I), images may reveal thinning of the long bones with thin cortices. Several wormian bones may be present. No deformity of long bones is observed.
In extremely severe OI (type II), the survey may reveal beaded ribs, broad bones, and numerous fractures with deformities of the long bones. Platyspondylia may also be revealed.
In moderate and severe OI (types III and IV), imaging may reveal cystic metaphyses, or a popcorn appearance of the growth cartilage. Normal or broad bones are revealed early, with thin bones revealed later. Fractures may cause deformities of the long bones. Old rib fractures may be present. Vertebral fractures are common.
Dual x-ray absorptiometry (DEXA) may be used to assess bone mineral density in children with milder forms of OI. Bone mineral density, as measured with DEXA, is low in children and adults with OI regardless of severity. Bone mineral densities can be normal in infants with OI, even in severe cases. In pediatric patients, DEXA results are not useful for predicting the risk of fracture. No reliable published reference data regarding DEXA in infants are available.
Densitometric bone scanning with computed tomography (CT) may be helpful in atypical cases of OI, though normal bone density does not exclude mild forms of the disease.
Polarized light microscopy or microradiography may be used in combination with scanning electron microscopy to assess dentinogenesis imperfecta.
With skin biopsy, collagen can be isolated from cultured fibroblasts and assessed for defects, with an accuracy of 85-87%.
Bone biopsy may show changes in the concentrations of noncollagenous bone proteins, such as osteonectin, sialoprotein, and decorin.
The width of biopsy cores, the width of the cortex, and the volume of cancellous bone are decreased in all types of OI. The number and thickness of trabeculae are reduced.
Samples may show evidence of defects in modeling of external bone in terms of the size and shape, the production of secondary trabeculae by endochondral ossification, and the thickening of secondary trabeculae by remodeling. Therefore, OI might be regarded as a disease of the osteoblast.
Bone formation is quantitatively decreased, but the quality of the bone material is probably most important in the pathogenesis of the disease.
Smith R, Francis MJ, Houghton GR. The brittle bone syndrome. In: Osteogenesis Imperfecta. London: Butterworth. 1983.
Brusin JH. Osteogenesis imperfecta. Radiol Technol. 2008 Jul-Aug. 79(6):535-48. [Medline].
Cole WG. The Nicholas Andry Award-1996. The molecular pathology of osteogenesis imperfecta. Clin Orthop. 1997 Oct. 235-48. [Medline].
Cole WG. Advances in osteogenesis imperfecta. Clin Orthop. 2002 Aug. 6-16. [Medline].
Cole WG. Bone, cartilage and fibrous tissue disorders. In: Benson MKD, Fixsen JA, MacNicol MF, Parch K, eds. Children's Orthopaedics. 2002: 67-92.
Baujat G, Lebre AS, Cormier-Daire V, Le Merrer M. [Osteogenesis imperfecta, diagnosis information (clinical and genetic classification)]. Arch Pediatr. 2008 Jun. 15(5):789-91. [Medline].
Alanay Y, Avaygan H, Camacho N, Utine GE, Boduroglu K, Aktas D, et al. Mutations in the gene encoding the RER protein FKBP65 cause autosomal-recessive osteogenesis imperfecta. Am J Hum Genet. 2010 Apr 9. 86(4):551-9. [Medline]. [Full Text].
Wallace DJ, Chau FY, Santiago-Turla C, Hauser M, Challa P, Lee PP, et al. Osteogenesis imperfecta and primary open angle glaucoma: genotypic analysis of a new phenotypic association. Mol Vis. 2014. 20:1174-81. [Medline]. [Full Text].
Sillence D. Osteogenesis imperfecta: an expanding panorama of variants. Clin Orthop. 1981 Sep. 11-25. [Medline].
Sillence DO, Senn A, Danks DM. Genetic heterogeneity in osteogenesis imperfecta. J Med Genet. 1979 Apr. 16(2):101-16. [Medline].
Labuda M, Morissette J, Ward LM. Osteogenesis imperfecta type VII maps to the short arm of chromosome 3. Bone. 2002 Jul. 31(1):19-25. [Medline].
Ward LM, Rauch F, Travers R. Osteogenesis imperfecta type VII: an autosomal recessive form of brittle bone disease. Bone. 2002 Jul. 31(1):12-8. [Medline].
Duro Friedl EA, Ferrari Mayans L, Desalvo Portal LN, Ferrari Ruiz P, Bidondo Horno MP, Astraldi Tellechea MM. [Bruck syndrome: Osteogenesis imperfecta with congenital joint contractures.]. An Pediatr (Barc). 2008 Jul. 69(1):90-1. [Medline].
Trehan SK, Morakis E, Raggio CL, Twomey KD, Green DW. Acetabular Protrusio and Proximal Femur Fractures in Patients With Osteogenesis Imperfecta. J Pediatr Orthop. 2014 Nov 6. [Medline].
Francis MJ, Smith R, Bauze RJ. Instability of polymeric skin collagen in osteogenesis imperfecta. Br Med J. 1974 Mar 9. 1(905):421-4. [Medline].
Rauch F, Travers R, Parfitt AM, Glorieux FH. Static and dynamic bone histomorphometry in children with osteogenesis imperfecta. Bone. 2000 Jun. 26(6):581-9. [Medline].
Jones D, Hosalkar H, Jones S. The orthopaedic management of osteogenesis imperfecta. Clin Orthop. 2002. 16:374-88.
Zeitlin L, Fassier F, Glorieux FH. Modern approach to children with osteogenesis imperfecta. J Pediatr Orthop B. 2003 Mar. 12(2):77-87. [Medline].
Forin V. [Paediatric osteogenesis imperfecta: medical and physical treatment]. Arch Pediatr. 2008 Jun. 15(5):792-3. [Medline].
Esposito P, Plotkin H. Surgical treatment of osteogenesis imperfecta: current concepts. Curr Opin Pediatr. 2008 Feb. 20(1):52-7. [Medline].
Sofield HA, Page MA, Mead NC. Multiple osteotomies and metal-rod fixation for osteogenesis imperfecta. J Bone Joint Surg. 1952. 34A:500-2.
Glorieux FH, Bishop NJ, Plotkin H, et al. Cyclic administration of pamidronate in children with severe osteogenesis imperfecta. N Engl J Med. 1998 Oct 1. 339(14):947-52. [Medline].
Salehpour S, Tavakkoli S. Cyclic pamidronate therapy in children with osteogenesis imperfecta. J Pediatr Endocrinol Metab. 2010 Jan-Feb. 23(1-2):73-80. [Medline].
Rauch F, Munns C, Land C, Glorieux FH. Pamidronate in children and adolescents with osteogenesis imperfecta: effect of treatment discontinuation. J Clin Endocrinol Metab. 2006 Apr. 91(4):1268-74. [Medline].
Shapiro JR, Thompson CB, Wu Y, Nunes M, Gillen C. Bone Mineral Density and Fracture Rate in Response to Intravenous and Oral Bisphosphonates in Adult Osteogenesis Imperfecta. Calcif Tissue Int. 2010 Jun 11. [Medline].
Gallego L, Junquera L, Pelaz A, Costilla S. Pathological mandibular fracture after simple molar extraction in a patient with osteogenesis imperfecta treated with alendronate. Med Oral Patol Oral Cir Bucal. 2010 Jun 1. [Medline].
Castillo H, Samson-Fang L. Effects of bisphosphonates in children with osteogenesis imperfecta: an AACPDM systematic review. Dev Med Child Neurol. 2009 Jan. 51(1):17-29. [Medline].
Kusumi K, Ayoob R, Bowden SA, Ingraham S, Mahan JD. Beneficial effects of intravenous pamidronate treatment in children with osteogenesis imperfecta under 24 months of age. J Bone Miner Metab. 2014 Oct 16. [Medline].
Hald JD, Evangelou E, Langdahl BL, Ralston SH. Bisphosphonates for the Prevention of Fractures in Osteogenesis Imperfecta: Meta-Analysis of Placebo-Controlled Trials. J Bone Miner Res. 2014 Nov 18. [Medline].
Bargman R, Huang A, Boskey AL, Raggio C, Pleshko N. RANKL inhibition improves bone properties in a mouse model of osteogenesis imperfecta. Connect Tissue Res. 2010 Apr. 51(2):123-31. [Medline]. [Full Text].
Wekre LL, Frøslie KF, Haugen L, Falch JA. A population-based study of demographical variables and ability to perform activities of daily living in adults with osteogenesis imperfecta. Disabil Rehabil. 2010. 32(7):579-87. [Medline].
|Type||Genetic||Teeth||Bone Fragility||Bone Deformity||Sclera||Spine||Skull||Prognosis|
|IA||AD*||Normal||Variable but less severe than other types||Moderate||Blue||20% scoliosis and kyphosis||Wormian bones||Fair|
|II||AD||Unknown||Very severe||Multiple fractures||Blue||NA||Wormian bones with absence of ossification||Perinatal death|
|III||AD||Dentinogenesis imperfecta||Severe||Progressive bowing of long bones and spine||Bluish at birth but white in adults||Kyphoscoliosis||Hypoplastic wormian bones||Wheelchair-bound, not ambulatory|
|IVA||AD||Normal||Moderate||Moderate||White||Kyphoscoliosis||Hypoplastic wormian bones||Fair|
|* AD = autosomal dominant; NA = not applicable.|